About Cipher Pharmaceuticals Inc. (CPHRF) — Dividend Analysis 2026
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug. The company's licensed products comprise CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a formulation of the active ingredient fenofibrate used for the treatment of hyperlipidemia, a cholesterol disorder; and Conzip/Durela (CIP- Tramadol), a formulation of the active ingredient tramadol for the management of moderate to moderately severe pain. Its pipeline products include Trevyent, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension; CF-101 for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical formulation of terbinafine for the treatment of onychomycosis; and DTR-001, a tattoo removal cream. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada.
Is CPHRF a good dividend investment in 2026?
CPHRF offers a 15.38% forward yield with a 50% payout ratio. Strand Safety Score: 45/100 (Moderate Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
CPHRF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your CPHRF portfolio grows to $11.90M vs $10.26M without reinvestment. This is the compound interest effect in action.
CPHRF dividend growth history & forecast
CPHRF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 15.38%.
FCF ($30M) is below dividends paid ($51M) — risk of cut (FCF: $30M · Dividends est.: $51M)
Debt Leverage0.0× Debt/EBITDA
30 / 30 pts
30/30
Debt/EBITDA 0.0× — low leverage, balance sheet is strong
Earnings Momentum+0.0B → +0.0B → +0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
Dividend at moderate risk — monitor coverage and debt closely.
STRAND SCORE
45
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 CPHRF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CPHRF.
Gross yield
15.38%
Tax rate
15.00%
After-tax yield
13.07%
Real yield (−CPI)
10.27%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
15.38%
12.58%
$1,538 / yr
🇺🇸 US Taxable (15%) ✓
15%
13.07%
10.27%
$1,307 / yr
🇺🇸 US Taxable (20%)
20%
12.30%
9.50%
$1,230 / yr
🇬🇧 UK ISA
0%
15.38%
12.58%
$1,538 / yr
🇬🇧 UK Taxable
8.75%
14.03%
11.23%
$1,403 / yr
🇨🇦 TFSA
0%
15.38%
12.58%
$1,538 / yr
🇨🇦 CA Taxable
25%
11.54%
8.73%
$1,154 / yr
🇦🇺 Super (pension)
15%
13.07%
10.27%
$1,307 / yr
🇦🇺 AU Taxable
30%
10.77%
7.97%
$1,077 / yr
🇩🇪 DE Taxable
26.375%
11.32%
8.52%
$1,132 / yr
🇫🇷 FR Taxable
30%
10.77%
7.97%
$1,077 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CPHRF Income Goal & Break-Even
Dividend Break-Even
8yr
Years for dividends to fully repay your CPHRF investment of $13.00/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$14.5K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$12.0K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in CPHRF for:
Shares needed
14,118
Capital required
$183,534
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CPHRF Dividend Payment Schedule
CPHRF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 CPHRF vs Healthcare Benchmarks
How CPHRF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+12.58% vs sectorBetter
CPHRF
15.38%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
CPHRF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
CPHRF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CPHRF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CPHRF Insider Activity
No recent SEC filings reported in the last 90 days.
📅
Next Earnings Report: 2026-05-07(in 37 days)EPS estimate: $0.14
🔬
Financial Health Scores
Altman Z-Score
8.16
✅ Safe Zone — low bankruptcy risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
8/9
✅ Strong fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CPHRF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →